Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-16
    E.g., 2018-10-16

Archive Search

Pages

60 results
3:25 PM, Jan 09, 2018  |  BioCentury | Finance

Stars in China

for Dsuvia sufentanil sublingual tablet (ARX-04) to treat moderate-to-severe acute pain in medically supervised settings Agile Therapeutics Inc
9:38 AM, Jan 05, 2018  |  BC Week In Review | Clinical News  |  Regulatory

Agile gets second CRL for Twirla

Agile Therapeutics Inc. (NASDAQ:AGRX) said on Dec. 22, 2017, that FDA issued a second complete response letter for …
FDA and identify a path for Twirla's approval. Twirla delivers low-dose ethinyl estradiol and levonorgestrel. Agile Therapeutics Inc
12:33 PM, Dec 22, 2017  |  BC Extra | Company News

Agile gets second CRL for Twirla

Agile Therapeutics Inc. (NASDAQ:AGRX) was off $2.24 (47%) to $2.52 on Friday after FDA issued a second complete …
4:29 PM, Oct 06, 2017  |  BioCentury | Finance

High as a Kite

CSE:ZEAL; NASDAQ:ZEAL) 8/9/17 $89.9 $548.9 $589.8 7% MyoKardia Inc. (NASDAQ:MYOK) 8/8/17 $142.9 $1,260.8 $1,521.8 21% Agile Therapeutics Inc
4:07 PM, Aug 28, 2017  |  BC Week In Review | Clinical News  |  Regulatory

FDA reviewing Agile's resubmitted NDA for contraceptive

Agile Therapeutics Inc. (NASDAQ:AGRX) said FDA accepted for review its resubmitted NDA for Twirla (seven-day contraceptive patch, AG200-15 …
Index to that of marketed contraceptive products in the U.S. (see BioCentury, April 21 ). Agile Therapeutics Inc
1:31 PM, Apr 21, 2017  |  BC Week In Review | Clinical News  |  Clinical Results

Twirla: Ph III SECURE data

for the product. This quarter, Agile plans to resubmit an NDA to FDA for Twirla. Agile Therapeutics Inc
12:00 AM, Apr 04, 2016  |  BioCentury | Finance

Fundamental reset

2/18/16 $7.6 $105.0 $116.7 11% Mast Therapeutics Inc. (NYSE-M:MSTX) (A) 2/10/16 $8.0 NA $52.6 NA Agile Therapeutics Inc
12:00 AM, Feb 08, 2016  |  BC Week In Review | Financial News  |  Other Financial News

Agile Therapeutics financial update

Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J.   Business: Genitourinary, Endocrine/Metabolic   Date announced: 2016-02-04   Note: Agile Therapeutics raised …
12:00 AM, Jan 25, 2016  |  BC Week In Review | Financial News  |  Completed Offerings

Agile Therapeutics completes follow-on

Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J.   Business: Genitourinary, Endocrine/Metabolic   Date completed: 2016-01-22   Type: Follow-on   …
12:00 AM, Mar 02, 2015  |  BC Week In Review | Financial News  |  Completed Offerings

Agile Therapeutics Inc completes debt financing

Agile Therapeutics Inc . (NASDAQ:AGRX), Princeton, N.J.   Business: Genitourinary, Endocrine/Metabolic   Date completed: 2015-02-24   Type: Debt …
financing   Raised: $16.5 million   Investor: Hercules Technology Growth Capital   Note: Agile Therapeutics drew down …

Pages